Forum Topic News
  • Conversation: Non Invasive Glucose Monitoring Device Moves Forward With Series B Funding

    • June 11, 2018 1:09 PM BST
    • Non Invasive Glucose Monitoring Device Moves Forward With Series B Funding

      RSP Systems, a Danish non-invasive diagnostics company, has completed the first of two rounds of a Series B fundraising to bring its diagnostic device for diabetes closer to regulatory approval and a market launch. If successful, RSP’s device could provide a non-invasive, more pleasant alternative to blood testing for diabetes patients by using light to measure the concentration of sugar in the blood.
      RSP’s technology uses a phenomenon called Raman scattering to measure blood sugar levels. Raman scattering occurs when light is shone on a molecule and scattered, changing the energy of the light. RSP uses Raman scattering to measure the concentration of a given molecule, in this case blood sugar, within cells and in fluid between tissues. The company recently published a study showing the accuracy of its technology was comparable to invasive blood sugar monitors, tested in 35 patients.
      Read more: https://labiotech.eu/rsp-systems-non-invasive-glucose-monitoring/

Add Reputation

Do you want to add reputation for this member by this post?

or cancel